Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 103.504
Filtrer
1.
Clin Chim Acta ; 564: 119925, 2025 Jan 01.
Article de Anglais | MEDLINE | ID: mdl-39151672

RÉSUMÉ

BACKGROUND: In pediatric cardiology, the fact that some new biomarkers have assay-specific normal values has to be considered for correct clinical decisions. The current study aimed to provide age-adjusted normative values for NT-proBNP and Galectin-3 using the Abbott immunoassay system from a prospective French pediatric cohort sera collection and to validate our data for NT-proBNP on a second retrospective cohort. METHODS: We analyzed 283 consecutive samples for NT-proBNP and 140 samples for Galectin-3 collected from apparently healthy children (0-18 years) with outpatient treatment at our institution (Hôpital Necker-Enfants malades, Paris, France) during 24 months. RESULTS: For NT-proBNP and Galectin-3, we establish four age partitions, respectively two (<2 years / >2 years) and establish upper reference values and their 90 % CI for each biomarker (Galectin-3 (ng/mL): 56 [44-70] / 26 [23-29]). We evaluated the diagnostic performance of our upper reference values of NT-proBNP on a retrospective cohort (n = 428) with positive predictive value of 0.92. CONCLUSIONS: Using Abbott immunoassay system, we report age-specific reference values for NT-proBNP and for the first time for Galectin-3 in a healthy French pediatric cohort. These data call for larger cohort studies to define more robustly percentiles and diagnostic performance for NT-proBNP.


Sujet(s)
Galectine -3 , Peptide natriurétique cérébral , Fragments peptidiques , Humains , Enfant , Fragments peptidiques/sang , Adolescent , Enfant d'âge préscolaire , Nourrisson , France , Valeurs de référence , Peptide natriurétique cérébral/sang , Femelle , Galectine -3/sang , Études de cohortes , Mâle , Nouveau-né , Dosage immunologique/normes , Marqueurs biologiques/sang , Études rétrospectives , Galectines/sang
2.
RMD Open ; 10(4)2024 Oct 02.
Article de Anglais | MEDLINE | ID: mdl-39357925

RÉSUMÉ

RATIONAL: Studies are needed to determine if multimorbidity screening and management reduce the rate of multimorbidity accumulation in patients with chronic inflammatory rheumatic diseases (IRD). OBJECTIVES: This study evaluates the impact of systematic screening programme on patient care and hospitalisation rates. METHODS: Patients with IRD who participated in the screening programme (exposed patients) were identified within the French national health database and matched with controls. Two sets of analysis were performed: one with multivariate analysis and a second using a propensity score matching to ensure comparability between exposed patients and controls. The primary endpoint (PE) was a composite score assessing the dispensation of multimorbidity-preventing drugs, including vaccines, lipid-lowering agents, antiosteoporotic medications and antiplatelet drugs, during the year following the index date. RESULTS: The first analysis included 286 exposed patients and 858 controls, demonstrating a higher rate of meeting the PE in exposed patients (adjusted OR=1.6 (1.2-2.2), p<0.01). Propensity score matching resulted in 281 exposed patients and 281 controls. Exposed patients exhibited a significantly higher rate of meeting the PE compared with controls (54.8% vs 44.5%; OR=1.5; p=0.015), with increased utilisation of vaccines, cholesterol-lowering drugs and antiosteoporotic medications. Furthermore, emergency admission and hospitalisations for fracture, cardiovascular events or infection were significantly less frequent in the exposed group (7.1% vs 15.3%; OR=0.42, p<0.01), with a reduction in severe infections (0.7% vs 3.9%; p=0.03). CONCLUSION: Systematic multimorbidity screening in patients with IRD boosted preventive medication use and reduced hospital admissions, justifying time and resource allocation for screening.


Sujet(s)
Hospitalisation , Multimorbidité , Rhumatismes , Humains , Femelle , Mâle , Hospitalisation/statistiques et données numériques , Rhumatismes/traitement médicamenteux , Rhumatismes/complications , Rhumatismes/épidémiologie , Adulte d'âge moyen , Sujet âgé , Dépistage de masse , France/épidémiologie , Score de propension , Études cas-témoins , Adulte
3.
Vet Res ; 55(1): 129, 2024 Oct 03.
Article de Anglais | MEDLINE | ID: mdl-39363368

RÉSUMÉ

Bovine viral diarrhoea (BVD) is one of the most economically damaging livestock enzootic diseases in the world. BVD aetiological agents are three pestiviruses (BVDV-1, -2 and HoBi-like pestivirus), which exhibit high genetic diversity and complex transmission cycles. This considerably hampers the management of the disease, which is why eradication plans have been implemented in several countries. In France, a national plan has been in place since 2019. Our understanding of its impact on the distribution of BVDV genotypes is limited by the availability of French genetic data. Here, we conducted a molecular epidemiology study to refine our knowledge of BVDV genetic diversity in France, characterise its international relationships, and analyse national spatio-temporal genotypic distribution. We collated 1037 BVDV-positive samples throughout France between 2011 and 2023, with a greater sampling effort in two major cattle production areas. We developed a high-throughput sequencing protocol which we used to complete the 5'UTR genotyping of this collection. We show that two main BVDV-1 genotypes, 1e and 1b, account for 88% of genotyped sequences. We also identified seven other BVDV-1 genotypes occurring at low frequencies and three BVDV-2 samples (genotype 2c). Phylogenetic analyses indicate different worldwide distribution patterns between the two main BVDV-1 genotypes. Their relative frequencies present no major changes in France since the 1990s and few variations at the national scale. We also found some degree of local spatial structuring in western France. Overall, our results demonstrate the potential of large-scale sequence-based surveillance to monitor changes in the epidemiological situation of enzootic diseases.


Sujet(s)
Diarrhée virale bovine-maladie des muqueuses , Variation génétique , Génotype , France/épidémiologie , Animaux , Bovins , Diarrhée virale bovine-maladie des muqueuses/épidémiologie , Diarrhée virale bovine-maladie des muqueuses/virologie , Analyse spatio-temporelle , Virus de la diarrhée virale bovine de type 1/génétique , Phylogenèse , Virus de la diarrhée virale bovine de type 2/génétique , Virus de la diarrhée virale bovine/génétique , Virus de la diarrhée virale bovine/physiologie , Épidémiologie moléculaire
4.
BMC Med Educ ; 24(1): 1078, 2024 Sep 30.
Article de Anglais | MEDLINE | ID: mdl-39350156

RÉSUMÉ

INTRODUCTION: Training novice ophthalmology residents on the EyeSi® simulator increases cataract surgery safety. However, there is no consensus regarding how much training residents should perform before their first time on patients. We evaluated the French national training program through the analysis of the learning curves of novice residents. METHODS: This prospective multicentric pedagogic study was conducted with French novice residents. Each resident completed the recommended four two-hour training sessions and performed a standardized assessment simulating standard cataract surgery before the first session (A0), at the end of the first (A1), second (A2), third (A3) and fourth (A4) sessions. For each surgical step of each attempt, the following data were collected: score, odometer, completion time, posterior capsular rupture and cumulative energy delivered (ultrasounds) during phacoemulsification. A performance threshold was set at a score of 80/100 for each surgical step, 400/500 for the overall procedure. Only descriptive statistics were employed. RESULTS: Sixteen newly nominated ophthalmology residents were included. Median score progressively increased from 95 [IQR 53; 147]) at A0 to 425 [IQR 411; 451] at A4. Despite a significant progression, the "emulsification" step had the lowest A4 scores 86 [IQR 60; 94] without reduction in completion time, odometer or ultrasounds delivered. The rate of posterior capsular rupture decreased linearly from 75% at A0 to 13% at A4 during "emulsification" and from 69 to 0% during "irrigation and aspiration". At A4, only 25% [8; 53] of residents had > 80 at each step and only 75% [47; 92] had > 400/500 overall. CONCLUSION: A training program consisting of four two-hour sessions on the EyeSi simulator over four consecutive days effectively enhances the surgical skills of novice ophthalmology residents. Undergoing more training sessions may improve scores and decrease the incidence of surgical complications, particularly at the emulsification step of cataract surgery. The learning curves presented here can reassure residents who are progressing normally and help identify those who need a further personalized training program.  TRIAL REGISTRATION: ClinicalTrials registration number: NCT05722080 (first submitted 22/12/2022, first posted 10/02/2023).


Sujet(s)
Compétence clinique , Internat et résidence , Courbe d'apprentissage , Ophtalmologie , Formation par simulation , Humains , Études prospectives , Mâle , Ophtalmologie/enseignement et éducation , Femelle , Extraction de cataracte/enseignement et éducation , France , Adulte , Phacoémulsification/enseignement et éducation , Enseignement spécialisé en médecine
5.
PLoS One ; 19(10): e0308505, 2024.
Article de Anglais | MEDLINE | ID: mdl-39365779

RÉSUMÉ

To better identify the responses of phytoplankton blooms to warming conditions as expected in a climate change context, an in situ mesocosm experiment was carried out in a coastal Mediterranean lagoon (Thau Lagoon, South of France) in April 2018. Our objective was to assess both the direct and indirect effects of warming on phytoplankton, particularly those mediated by top-down control. Four treatments were applied: 1) natural planktonic community with ambient water temperature (C); 2) natural planktonic community at +3°C elevated temperature (T); 3) exclusion of larger zooplankton (> 200 µm; mesozooplankton) leaving microzooplankton predominant with ambient water temperature (MicroZ); and 4) exclusion of larger zooplankton (> 200 µm; mesozooplankton) at +3°C elevated temperature (TMicroZ). Warming strongly depressed the amplitude of the phytoplankton bloom as the chlorophyll a concentration was twice lower in the T treatment. This decline under warmer conditions was most likely imputed to increase top-down control by zooplankton. However, removal of mesozooplankton resulted in an opposite trend, with a higher bloom amplitude observed under warmer conditions (MicroZ vs. TMicroZ) pointing at a strong interplay between micro- and mesozooplankton and the effect of warming for the spring phytoplankton blooms. Furthermore, both warming and mesozooplankton exclusion induced shifts in phytoplankton community composition during bloom and post-bloom periods, favoring dinoflagellates and small green algae at the expense of diatoms and prymnesiophytes. Moreover, warming altered phytoplankton succession by promoting an early bloom of small green flagellates, and a late bloom of diatoms. Our findings clearly highlighted the sensitivity of phytoplankton blooms amplitudes, community composition and succession patterns to temperature increases, as well as the key role of initial zooplankton community composition to elicit opposite response in bloom dynamics. It also points out that warmer conditions might favor dinoflagellates and small green algae, irrespective of zooplankton community composition, with potential implications for food web dynamics and energy transfer efficiency under future ocean condition.


Sujet(s)
Phytoplancton , Zooplancton , Phytoplancton/physiologie , Phytoplancton/croissance et développement , Zooplancton/physiologie , Animaux , Température , France , Changement climatique , Eutrophisation , Chlorophylle A/métabolisme , Chlorophylle A/analyse , Chaine alimentaire , Chlorophylle/métabolisme , Saisons , Réchauffement de la planète
6.
Soins ; 69(889): 38-40, 2024 Oct.
Article de Français | MEDLINE | ID: mdl-39368820

RÉSUMÉ

In France, 1.5 million women live with diabetes. This chronic metabolic disease disrupts every aspect of the lives of sufferers, right down to the most intimate. The impact of diabetes on women's sexuality is less well documented than for men. Yet a holistic approach to the management of the disease is essential to provide quality care.


Sujet(s)
Complications du diabète , Humains , Femelle , Santé sexuelle , France/épidémiologie , Troubles sexuels d'origine physiologique/étiologie
7.
Soins ; 69(889): 55-59, 2024 Oct.
Article de Français | MEDLINE | ID: mdl-39368825

RÉSUMÉ

The number of advanced practice nurses (APNs) is constantly growing, and this means that they are being deployed in settings other than hospitals or private practice. Long-term care units and residential establishments for dependent elderly people are among the places where these professionals are being deployed. Their main missions are to improve patient and resident follow-up and care, develop therapeutic education and promote best practices. Here's an example of APN implementation in a residential establishment for dependent elderly people. This is a recent activity, which should evolve in the future.


Sujet(s)
Pratique infirmière avancée , Humains , France , Sujet âgé , Maisons de retraite médicalisées/organisation et administration , Rôle de l'infirmier
8.
J Med Virol ; 96(10): e29948, 2024 Oct.
Article de Anglais | MEDLINE | ID: mdl-39363782

RÉSUMÉ

Surveillance studies of Transmitted Drug Resistance (TDR) are crucial in tracking the evolution of HIV epidemiology. Our aim was to investigate TDR to nucleoside reverse transcriptase inhibitors (NRTIs), non-nucleoside reverse transcriptase inhibitors (NNRTIs), protease inhibitors (PIs), integrase inhibitors (INIs), as well as to new drugs: lenacapavir, fostemsavir. Predictive sensitivity was evaluated for maraviroc and broadly neutralizing antibodies (bNAbs) (zinlirvimab and teropavimab). Between 2020 and 2023, 85 people with HIV (PWH) were diagnosed with primary HIV-1 infection (PHI). Pol and env sequences were analyzed and TDR was characterized according to the French ANRS algorithm. The genotypic-based prediction of bNAbs sensitivity was based on HIV env amino acid signatures I108, I201, F353 for teropavimab and N325, N332, H330 for zinlirvimab. TDR to NRTIs, NNRTIs, PIs and INIs was evidenced in 8.2%, 12.9%, 4.7%, and 5.9% strains, respectively. Ten viruses were CXCR4/dual mix. All viruses were susceptible to lenacapavir (100%) and 52% harbored resistance to fostemsavir. The genotypic profile was associated with a predictive positive value (PPV) > 83% of susceptibility to both teropavimab and zinlirvimab for 23 viruses (31%), while 22 (29%) had a PPV between 62% and 75%, suggesting reduced susceptibility to both bNAbs as soon as primary infection. The surveillance of TDR evidenced at the time of PHI is important with regard to new strategies for HIV patients with virological failure and global implementation of PrEP using NRTI, INI such as recently approved injectable cabotegravir, and future long-acting drugs such as lenacapavir and bNAbs.


Sujet(s)
Agents antiVIH , Anticorps neutralisants , Résistance virale aux médicaments , Infections à VIH , VIH-1 (Virus de l'Immunodéficience Humaine de type 1) , Humains , Infections à VIH/virologie , Infections à VIH/traitement médicamenteux , Infections à VIH/épidémiologie , Infections à VIH/immunologie , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/effets des médicaments et des substances chimiques , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/immunologie , VIH-1 (Virus de l'Immunodéficience Humaine de type 1)/génétique , France/épidémiologie , Anticorps neutralisants/immunologie , Mâle , Agents antiVIH/usage thérapeutique , Agents antiVIH/pharmacologie , Femelle , Adulte , Résistance virale aux médicaments/génétique , Adulte d'âge moyen , Organophosphates/pharmacologie , Génotype , Anticorps anti-VIH/immunologie , Pipérazines
9.
BMC Public Health ; 24(1): 2691, 2024 Oct 02.
Article de Anglais | MEDLINE | ID: mdl-39358770

RÉSUMÉ

BACKGROUND: Few studies evaluated the use of Household Disinfectant and Cleaning Products (HDCPs) during the COVID-19 pandemic, but no population-based cohorts used longitudinal data. We studied changes in HDCPs during the first lockdown, based on longitudinal data from the French population-based NutriNet-Santé and CONSTANCES cohorts. METHODS: Based on standardized questionnaires on household cleaning tasks in 2018-2019 and around the first lockdown in France (March17-May3 2020), we compared the duration of weekly use of HDCPs (< 1 day/week, < 10 min/week; 10-30 min/week; > 30 min/week) and the household cleaning help (yes/no) before and during the lockdown period by Bhapkar and McNemar's tests. Moreover, we assessed self-reported changes in the frequency of HDCPs during the lockdown from before (unchanged/increased). RESULTS: Analyses were carried on 31,105 participants of NutriNet-Santé (48 years, 75% women, 81% ≥ high school diploma) and 49,491 of CONSTANCES (47 years, 51% women, 87% ≥ high school diploma). During the lockdown, compared with 2018-2019, duration of HDCPs use increased (> 30 min; NutriNet-Santé: 44% versus 18%; CONSTANCES: 63% versus 16%) and household help decreased (NutriNet-Santé: 5% versus 40%; CONSTANCES: 3% versus 56%). Regarding the frequency of HDCPs use, 55% of participants of NutriNet-Santé (57% women/49% men) and 83% of CONSTANCES (86% women/81% men) reported an increased use since the beginning of the lockdown, significantly higher among women (p < 0.0001). CONCLUSIONS: The frequency and duration of weekly use of HDCPs has significantly increased since the pandemic. As the use of HDCPs is associated with health issues, further studies are now needed to evaluate the potential health impacts of these changes.


Sujet(s)
COVID-19 , Désinfectants , Humains , France/épidémiologie , COVID-19/épidémiologie , COVID-19/prévention et contrôle , Femelle , Mâle , Adulte d'âge moyen , Quarantaine , Adulte , Détergents , Études longitudinales , Contrôle des maladies transmissibles/méthodes , Enquêtes et questionnaires , Produits domestiques , SARS-CoV-2 , Ménage/statistiques et données numériques , Pandémies
10.
JAMA Netw Open ; 7(10): e2436723, 2024 Oct 01.
Article de Anglais | MEDLINE | ID: mdl-39352700

RÉSUMÉ

Importance: Most observational studies examining the association between hearing loss (HL) and cognitive impairment used subjective measures of hearing and addressed only one dimension of cognition, and very few investigated the potential benefit of hearing aids (HAs). Objective: To evaluate objectively measured HL and several dimensions of cognition and estimate the association with HA use. Design, Setting, and Participants: A cross-sectional analysis of the CONSTANCES cohort study, which recruited participants from January 1, 2012, to December 31, 2020, was conducted. Participants were a representative sample of adults (age, 45-69 years) with audiometric data and cognitive evaluation from 21 preventive health centers in France. Data analysis was conducted from April 1 to September 15, 2023. Exposure: The main exposure was HL, which was defined by a pure-tone average in the best ear higher than 20 dB hearing level for mild loss and 35 dB hearing level for disabling loss. Secondary exposure was self-reported HA use. Main Outcomes and Measures: Cognition was evaluated at study inclusion by a standardized battery of 5 cognitive tests conducted by trained neuropsychologists. A global cognitive score was computed from principal component analysis and global cognitive impairment was defined as having a score less than or equal to the 25th percentile of the distribution. Results: The study population included 62 072 participants with audiometric data (mean [SD] age, 57.4 [7] years; 52% women). Overall, 38% (n = 23 768) had mild HL, 10% (n = 6012) had disabling HL, and 3% (n = 1668) were HA users. In multivariable analyses, mild HL (odds ratio [OR], 1.10; 95% CI, 1.05-1.15) and disabling HL (OR, 1.24; 95% CI, 1.16-1.33) were associated with greater global cognitive impairment. The odds of cognitive impairment did not differ significantly between all participants with HA use and participants with disabling HL without HAs (OR, 0.94; 95% CI, 0.83-1.07), except among participants with depression (OR, 0.62; 95% CI, 0.44-0.88). Conclusions and Relevance: In this cohort study, an association between the severity of HL and global cognitive impairment was found. The use of HAs was not associated with significantly lower odds of cognitive impairment. The findings suggest that it may be useful to monitor cognitive function in middle-aged individuals with HL.


Sujet(s)
Cognition , Dysfonctionnement cognitif , Aides auditives , Perte d'audition , Humains , Adulte d'âge moyen , Femelle , Aides auditives/statistiques et données numériques , Mâle , Sujet âgé , Études transversales , Perte d'audition/épidémiologie , Dysfonctionnement cognitif/épidémiologie , Cognition/physiologie , France/épidémiologie , Études de cohortes
11.
Tech Coloproctol ; 28(1): 138, 2024 Oct 03.
Article de Anglais | MEDLINE | ID: mdl-39361109

RÉSUMÉ

BACKGROUND: Postoperative rectovaginal fistula leads to a loss of patients' quality of life and presents significant challenges to the surgeon. The literature focusing specifically on postoperative rectovaginal fistulas is limited. The objective of the present study is to identify factors that can enhance the success of the management of this postoperative rectovaginal fistula. METHODS: This retrospective multicentric study included all patients undergoing surgery for rectovaginal fistulas, excluding those for whom the etiology of rectovaginal fistula was not postoperative. The major outcome measure was the success of the procedure. RESULTS: A total of 82 patients with postsurgical fistulas were identified, of whom 70 were successfully treated, giving a success rate of 85.4%. On average, these patients required 3.04 ± 2.72 interventions. The creation of a diversion stoma did not increase the success rate of management [odds ratio (OR) = 0.488; 95% confidence interval (CI) 0.107-2.220]. Among the 217 procedures performed, 69 were successful, accounting for a 31.8% success rate. The number of interventions and the creation of a diversion stoma did not correlate with the success of management. However, direct coloanal anastomosis was significantly associated with success (OR = 35.06; 95% CI 1.271-997.603; p = 0.036) as compared with endorectal advancement flap (ERAF). Other procedures such as Martius flap did not show a significantly higher success rate. CONCLUSION: The creation of a diversion stoma is not necessary in closing a fistula. ERAF should be considered as a first-line treatment prior to proposing more invasive approach such as direct coloanal anastomosis.


Sujet(s)
Complications postopératoires , Fistule rectovaginale , Stomies chirurgicales , Humains , Femelle , Études rétrospectives , Fistule rectovaginale/chirurgie , Fistule rectovaginale/étiologie , Adulte d'âge moyen , France , Complications postopératoires/étiologie , Complications postopératoires/chirurgie , Stomies chirurgicales/effets indésirables , Adulte , Sujet âgé , Résultat thérapeutique , Anastomose chirurgicale/effets indésirables , Anastomose chirurgicale/méthodes
12.
Trials ; 25(1): 654, 2024 Oct 03.
Article de Anglais | MEDLINE | ID: mdl-39363224

RÉSUMÉ

BACKGROUND: Urinary tract infections are common affections, especially for women. Difficult access to a general practitioner to obtain a prescription has led France to offer dispensing under protocol by community pharmacists. The primary objective of this study is to evaluate the effectiveness of a pharmacist care protocol provided to manage women with urinary tract infection symptoms. This objective will be assessed using the Acute Cystitis Symptom Score. METHODS: PharmaCyst' is an open-label, multicenter, controlled, cluster-randomized study conducted in the Loire region, France. Women aged between 18 and 65 years presenting to a pharmacy complaining of at least one symptom of an uncomplicated urinary tract infection present over the last 3 days (including burning pain during micturition, dysuria, pollakiuria, urgent urination) will be considered for inclusion. All patients will be contacted on day 3, 10, and month 3. A total of 480 patients need to be recruited for the 24 clusters participating in the research. The quantitative data will be described using means and standard deviations and compared using Student's t-test. The qualitative data will be described using numbers and percentages and compared using chi2 test (or Fisher's exact test if necessary). The primary and secondary outcomes analyses will consider the intention-to-treat population. DISCUSSION: PharmaCyst' is the first clinical trial conducted in France only by community pharmacists. Its results could lead to an extension of the protocol. TRIAL REGISTRATION: The protocol has been approved by the French ethics committee on 2022/12/02 and is registered under the number 49RC22_0240 on ClinicalTrials.gov.


Sujet(s)
Services des pharmacies communautaires , Cystite , Études multicentriques comme sujet , Pharmaciens , Humains , Femelle , France , Adulte , Adulte d'âge moyen , Adolescent , Cystite/diagnostic , Cystite/thérapie , Cystite/traitement médicamenteux , Jeune adulte , Sujet âgé , Essais contrôlés randomisés comme sujet , Résultat thérapeutique , Infections urinaires/diagnostic , Infections urinaires/traitement médicamenteux , Facteurs temps
13.
Hematol Oncol ; 42(6): e3314, 2024 Nov.
Article de Anglais | MEDLINE | ID: mdl-39351974

RÉSUMÉ

Marginal Zone Lymphoma (MZL) comprises three subtypes: extranodal MZL (EMZL), splenic MZL (SMZL) and nodal MZL (NMZL). Since clinical trials have limited representativeness, there is a need for real-world data (RWD) evidence in MZL. Real-world data in Lymphoma and survival in Adults (REALYSA) is a prospective multicentric French cohort of newly diagnosed lymphoma patients. This study consists of the first abstraction of MZL patients prospectively included in REALYSA between 12/2018 and 01/2021 with at least 1 year of follow-up. It provides a landscape description of clinical characteristics, initial workup, quality of life and first-line therapy performed in routine practice. Among 207 included patients, 122 presented with EMZL, 51 with SMZL and 34 with NMZL. At baseline, median age was 67 years (range 28-96), and patients reported a favorable global health status (75/100 (IQR 58,83)) - which was higher in NMZL and lower in SMZL patients (p = 0.006). 18FDG-PET/CT was frequently performed at initial workup (EMZL 72%, SMZL 73%, NMZL 85%). Active surveillance was the initial management for 58 (28%) patients. The most prescribed therapies were rituximab-chlorambucil in the EMZL population (30%), rituximab monotherapy in the SMZL population (37%) and R-CHOP (24%)/bendamustine-rituximab (15%) in the NMZL population. At end of first line, overall response rate was 93% among treated patients with 75% of complete response. This French nationwide study provided for the first time prospective RWD on clinical characteristics, initial management and treatment response of MZL patients.


Sujet(s)
Lymphome B de la zone marginale , Humains , Lymphome B de la zone marginale/thérapie , Lymphome B de la zone marginale/anatomopathologie , Lymphome B de la zone marginale/diagnostic , Lymphome B de la zone marginale/épidémiologie , Lymphome B de la zone marginale/mortalité , Lymphome B de la zone marginale/traitement médicamenteux , Adulte d'âge moyen , Mâle , Femelle , Sujet âgé , Adulte , France/épidémiologie , Sujet âgé de 80 ans ou plus , Protocoles de polychimiothérapie antinéoplasique/usage thérapeutique , Études prospectives , Rituximab/administration et posologie , Rituximab/usage thérapeutique , Taux de survie , Études de suivi
14.
Aging Male ; 27(1): 2406547, 2024 Dec.
Article de Anglais | MEDLINE | ID: mdl-39364940

RÉSUMÉ

OBJECTIVES: To compare the evolution of health-related quality of life (HRQoL) over 6 months of GnRH agonist (GnRHa) therapy among age groups for patients with prostate cancer (PCa). PATIENTS AND METHODS: PRISME (NCT03516110) was a non-interventional, prospective study conducted in France in patients aged ≥60 years with PCa initiating GnRHa therapy within routine care. HRQoL was evaluated at baseline and after 6 months using the EORTC quality of life in ELDerly cancer patients 14 items (QLQ-ELD14) questionnaire. Cognitive status was assessed using the Mini Mental State Examination (MMSE). Analyses of covariance compared the evolution of the change from baseline of the QLQ-ELD14 scores among age groups. RESULTS: 814 patients were enrolled (245, 60-70 years; 314, 70-75 years; 252, ≥75 years). Slight or no changes were observed in each QLQ-ELD14 dimension between baseline and 6 months, overall and by age. In the primary effectiveness analysis, there was no difference among age groups in the change from baseline in QLQ-ELD14 scores. Baseline cognitive status was lower in the oldest age group, but there were no changes in all age groups. As expected, sexual function declined in all age groups. CONCLUSION: GnRHa therapy influence on HRQoL, cognition and sexuality appeared independent of age.


Prostate cancer that has spread to other parts of the body is called "advanced prostate cancer." Hormone therapy is a common treatment for high risk localized and advanced prostate cancer. It works by lowering hormone levels, causing prostate cancers to grow more slowly or shrink. But, side effects from this kind of treatment can affect a patient's quality of life. Common side effects of hormone therapy include a loss of sex drive, erectile dysfunction, bone weakening, hot flushes, or mood disorders. Most patients with prostate cancer are over the age of 60 years, but elderly patients are often excluded from clinical trials, meaning that we lack data about them. This study assessed if there was a link between age and health-related quality of life in men with advanced prostate cancer treated with hormone therapy. The study included 814 men with advanced prostate cancer who were over 60 years old and had started a type of hormone therapy called gonadotropin-releasing hormone agonist (GnRHa) therapy. The results showed that health-related quality of life was similar after 6 months of hormone therapy, in the overall group of patients and in the different age groups (60­70, 70­75, and over 75 years of age). Cognitive impairment occurred about twice as often in patients aged over 75 years than among younger patients, before initiation of hormone therapy. Cognitive impairment was likely caused by ageing and was not associated with hormone therapy treatment. Sexual function decreased in all age groups, particularly in patients aged 60­70 years. This study did not reveal any major impact of hormone therapy on health-related quality of life in older men with advanced prostate cancer, after a 6-month period and the use of routine questionnaires.


Sujet(s)
Hormone de libération des gonadotrophines , Tumeurs de la prostate , Qualité de vie , Sujet âgé , Sujet âgé de 80 ans ou plus , Humains , Mâle , Adulte d'âge moyen , Facteurs âges , Antinéoplasiques hormonaux/usage thérapeutique , France , Hormone de libération des gonadotrophines/agonistes , Études prospectives , Tumeurs de la prostate/traitement médicamenteux , Enquêtes et questionnaires
15.
Front Public Health ; 12: 1411099, 2024.
Article de Anglais | MEDLINE | ID: mdl-39371210

RÉSUMÉ

Purpose: Tobacco use remains the leading preventable cause of death in France, with 75,000 deaths each year. France aims to reduce smoking and achieve a smoke-free generation by 2032. However, recent tobacco industry innovations which mainly target young people, could undermine this goal. The main objective of this study is to assess the knowledge and consumption patterns of the "puff" among French adolescents in 2022. Methods: A cross-sectional study using a structured online survey on a representative sample of 400 adolescents aged 13 to 16 years was conducted from July 4th to 20th, 2022. Results: Around 66% of adolescents reported having heard of the puff", and one in ten having tried it. Slightly fewer of them have tried cigarettes; 89.6% of experimenters reported that it allowed them to explore unique flavors, 81.9% found it fun to play with the puff-cloud, and 94.5% of regular consumers considered it a stylish or cool product. 76% of adolescents believe that the puff is dangerous to their health, 71.6% describe it as a polluting device, and 62.8% think it's a gadget. Conclusion: The "puff" is widely known by French adolescents and more commonly used than cigarettes, due, in part, to marketing specifically designed to target youth. That is why it could represent a threat to the smoke-free generation objectives. Public health policy could be informed by the ecological awareness of adolescents as a new lever of counter-influence to prevent this kind of consumption, as did ACT with the #stopcigarettespollution prevention campaign.


Sujet(s)
Connaissances, attitudes et pratiques en santé , Humains , Adolescent , France , Femelle , Mâle , Études transversales , Enquêtes et questionnaires , Comportement de l'adolescent/psychologie , Fumer/épidémiologie
16.
Environ Health ; 23(1): 79, 2024 Oct 04.
Article de Anglais | MEDLINE | ID: mdl-39367425

RÉSUMÉ

BACKGROUND: Organic solvents are used in formulating an extensive range of products for professional use. Animal and human studies suggest that in utero solvent exposure may affect neurodevelopment. Our objective was to assess the association between occupational exposure to solvents during pregnancy and child behavior aged 2-12 years. METHODS: The French mother-child cohort PELAGIE (2002-2006) included 3,421 women recruited in early pregnancy. Occupational exposure to solvents was self-reported. For 459 children, parents used a questionnaire derived from the Child Behavior Checklist and the Preschool Social Behavior Questionnaire to assess their child's behavior, at age 2, and the Strengths and Difficulties Questionnaire at ages 6 and 12. A cross-lagged structural equation modeling approach was used to assess direct and indirect associations between exposure and child behavior. RESULTS: At age 2, an increased externalizing behavior score was suggested with prenatal exposure to solvents (mean change in standardized score (95%CI): 0.28 (-0.01, 0.57) for occasional exposure and 0.23 (-0.05, 0.51) for regular exposure). At ages 6 and 12, distinct sex-specific patterns were observed: among boys, no association with externalizing behavior was observed, while among girls, an association was seen for both occasional and regular exposure (total effect at age 12: 0.45 (0.06,0.83) and 0.40 (0.03, 0.76), respectively). For both sexes, occasional exposure may be associated with internalizing behavior at ages 6 and 12 (total effect at age 6: 0.37 (0.06, 0.68) and at age 12: 0.27 (-0.08, 0.62)). CONCLUSIONS: Occupational exposure to solvents during pregnancy may impact child behavior through either direct or cumulative effects during childhood; these associations may persist until early adolescence, especially among girls.


Sujet(s)
Comportement de l'enfant , Exposition professionnelle , Effets différés de l'exposition prénatale à des facteurs de risque , Solvants , Humains , Femelle , Enfant , Solvants/toxicité , Grossesse , Enfant d'âge préscolaire , Effets différés de l'exposition prénatale à des facteurs de risque/induit chimiquement , Mâle , Comportement de l'enfant/effets des médicaments et des substances chimiques , Exposition professionnelle/effets indésirables , France/épidémiologie , Adulte , Exposition maternelle/effets indésirables , Adolescent
17.
Longit Life Course Stud ; 15(4): 464-477, 2024 Aug 26.
Article de Anglais | MEDLINE | ID: mdl-39371023

RÉSUMÉ

Socio-emotional skills, vital for navigating life's challenges, significantly influence educational success and well-being. Thus, socio-economic disparities in these skills may contribute to broader inequalities in achievement. Despite their importance, research in certain contexts, like France, remains limited. Self-efficacy, a cornerstone of socio-emotional well-being, develops early and it is influenced by familial and contextual factors. The primary school years are central for self-efficacy development. During this period, socio-economic gaps in self-efficacy may emerge, influenced by family environments and experiences at school. Using data from the 2011 Panel of Pupils we find that French pupils have similar academic self-efficacy whatever their socio-economic background at the start of primary school. However, at the end of primary school, children coming from more disadvantaged socio-economic backgrounds exhibit lower academic self-efficacy as compared to more advantaged peers, and this socio-economic gap is particularly strong among girls. The findings of this work underscore the need for educational policies to focus on socio-emotional skills development alongside cognitive skills from an early age to reduce socio-economic inequalities.


Sujet(s)
Établissements scolaires , Auto-efficacité , Facteurs socioéconomiques , Étudiants , Humains , France , Femelle , Mâle , Enfant , Étudiants/psychologie , Réussite universitaire
18.
PLoS One ; 19(10): e0307254, 2024.
Article de Anglais | MEDLINE | ID: mdl-39374247

RÉSUMÉ

When a fast kinetic natural disaster occurs, it is crucial that crisis managers quickly understand the extent of the situation, especially through the development of "big picture" maps. For many years, great efforts have been made to use social networks to help build this situational awareness. While there are many models for automatically extracting information from posts, the difficulty remains in detecting and geolocating this information on the fly so that it can be placed on maps. Whilst most of the work carried out to date on this subject has been based on data in English, we tackle the problem of detecting and geolocating natural disasters from French messages posted on the Twitter platform (now renamed "X"). To this end, we first build an appropriate dataset comprised of documents from the French Wikipedia corpus, the dataset from the CAp 2017 challenge, and a homemade annotated Twitter dataset extracted during French natural disasters. We then developed an Entity-Linking pipeline in adequacy with our end-application use case: real-time prediction and peak resiliency. We show that despite these two additional constraints, our system's performances are on par with state-of-the-art systems. Moreover, the entities geolocated by our model show a strong coherence with the spatiotemporal signature of the natural disasters considered, which suggests that it could usefully contribute to automatic social network analysis for crisis managers.


Sujet(s)
Catastrophes naturelles , Médias sociaux , Réseautage social , France , Humains
19.
Neurology ; 103(9): e209885, 2024 Nov 12.
Article de Anglais | MEDLINE | ID: mdl-39383482

RÉSUMÉ

BACKGROUND AND OBJECTIVES: Previous literature has been diverging on cancer risk in people with multiple sclerosis (PwMS). Therefore, this study compared the risk of cancer in PwMS and a matched sample from the French general population. METHODS: This 10-year nationwide retrospective matched cohort study (2012-2021) used data from the national French administrative health care database (99% coverage of the French population) to determine the time to the first incident cancer. PwMS were identified using their long-term disease (LTD) status, hospitalizations, and multiple sclerosis (MS)-specific drug reimbursements. The control population was matched 4:1 on age, sex, residence, insurance scheme, and cohort entry date. Participants were included if they had no history of cancer in the 3 years before inclusion. Patients with cancer were identified through LTD status, hospitalizations, chemotherapy, radiotherapy, or prostate cancer-specific drug reimbursements. Overall and cancer location-specific hazard ratios (HRs) for the first incident cancer were obtained from Fine and Gray models, and age- and sex-stratified estimates were reported. Participation in cancer screening through the 3 national programs (breast, colorectal, and cervical) were compared between groups. RESULTS: Cancer incidence was 799 per 100,000 person-years (PYs) (n = 8,368) among the 140,649 PwMS and 736 per 100,000 PYs (n = 31,796) among the 562,596 matched controls (70.8% of women; follow-up: 7.6 ± 3.2 years). A small overall risk increase was observed for PwMS (HR 1.06, 95% CI 1.03-1.08), mostly in women (HR 1.08, 95% CI 1.05-1.11). Risk varied by cancer types and was lower for prostate (HR 0.80, 95% CI 0.73-0.88), breast (HR 0.91, 95% CI 0.86-0.95), and colorectal (HR 0.90, 95% CI 0.84-0.97) cancer and higher for bladder (HR 1.71, 95% CI 1.54-1.89), brain (HR 1.68, 95% CI 1.42-1.98), and cervical (HR 1.24, 95% CI 1.12-1.38) cancer in PwMS. Cancer risk was higher in PwMS younger than 55 years (HR 1.20, 95% CI 1.15-1.24) but decreased in PwMS aged 65 years and older (HR 0.89, 95% CI 0.85-0.94). This trend was found in all cancer locations. There were fewer PwMS getting screened than controls (all programs), with a particularly pronounced difference among those aged 65 years and older. DISCUSSION: Cancer risk was slightly increased in PwMS, particularly for urogenital cancers, possibly due to surveillance bias. Risk fluctuated depending on age, perhaps due to varying generational screening practices (i.e., diagnosis neglect in the older PwMS) and risk factors.


Sujet(s)
Sclérose en plaques , Tumeurs , Humains , Mâle , Femelle , Sclérose en plaques/épidémiologie , Adulte d'âge moyen , Tumeurs/épidémiologie , Études rétrospectives , Adulte , Incidence , France/épidémiologie , Sujet âgé , Études de cohortes , Facteurs de risque , Jeune adulte
20.
Turkiye Parazitol Derg ; 48(3): 142-149, 2024 10 07.
Article de Anglais | MEDLINE | ID: mdl-39373587

RÉSUMÉ

OBJECTIVE: Toxoplasma gondii is an obligate intracellular protozoon that infects approximately one-third of the human population. The parasite could transmit from mother to fetus in cases of acute infection during pregnancy and cause complications in the fetus. The bibliometric analysis is a popular research area that evaluates all the studies indexed in particular databases on a subject. METHODS: This article puts forth bibliometric review of the literature on maternal and congenital toxoplasmosis research indexed in the Web of Science database between 1945 and 2024. VOS viewer, Web of Science and MS Office Excel 17 programs were used in the study. RESULTS: The results of the search showed 1476 publications. The countries that most contributed to the literature were France (n=306, 20.73%), the USA (n=229, 15.52%), and Brazil (n=146, 9.89%). The most cited country was also France (n=10271, 35.52%), followed by the USA (n=9113, 31.51%), and England (n=2611, 9.03%). The top three countries by number of citations per document were Denmark (44.88), the USA (39.79) and France (33.57). The five departments with the most publications are Pediatrics (20.26%), General Internal Medicine (18.16%), Infectious Diseases (16.8%), Obstetrics (14.57%), and Immunology (11.86%). Wallon M. (n=57), Peyron F. (n=49), Thulliez P. (n=36) and Vilena I. (n=36) were the leading authors in terms of contribution to the literature. The five most published journals were Pediatric Infectious Disease Journal (3.66%), Journal of Clinical Microbiology (2.78%), Lancet (2.3%), Presse Medicale (1.76%), and American Journal of Obstetrics and Gynecology (1.63%). CONCLUSION: France is one of the countries that pays the most attention to congenital toxoplasmosis and compatible with this, in our study, the country with the highest number of studies on congenital toxoplasmosis was France. It is thought that drawing more attention to this issue and conducting more studies in countries where the disease is common might yield successful results, as in France.


Sujet(s)
Bibliométrie , Toxoplasmose congénitale , Humains , Toxoplasmose congénitale/épidémiologie , Femelle , Grossesse , Toxoplasma , France/épidémiologie , Recherche biomédicale/tendances , États-Unis/épidémiologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE